Diagnostics

New Bay Area Lyme Foundation Study Shows Common FDA-Cleared Lyme Tests Miss 64-78% of Early Cases, Underscores Urgent Need for Improved Diagnostics

Research published in the Journal of Clinical MicrobiologyPORTOLA VALLEY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a...

BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease

Collaboration aims to identify biological signatures and patient subpopulations most likely to benefit from BioAegis’ recombinant human plasma gelsolin (rhu-pGSN),...

Ultima Genomics releases groundbreaking TRACERx MRD data showing ppmSeq performance and unveils clinical progress of whole genome sequencing at inaugural global MRD Symposium at AACR 2026

Presenting initial TRACERx MRD data showcasing low single-digit parts-per-million   sensitivity for ctDNA detection with ppmSeq Additional collaborations also demonstrate ultra-sensitive...

error: Content is protected !!